Nanotechnology Characterization Laboratory
|
Research Initiative
|
FDA
|
NCI, NIEHS
|
2004
|
|
NAPA Federal Research Subgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, ASPE, ACL, CDC, CMS, FDA, HRSA, IHS
|
NIA, NINDS
|
|
|
NASEM Aging Disability and Independence Forum
|
Committee, Advisory Group, or Work Group
|
ACL
|
NIA
|
2014
|
|
National Academies Addressing Evidence Gaps in Clinical Prevention (NAM Evidence Gaps project)
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
ODP
|
2020
|
|
National Academy of Medicine Committee on Emerging Science, Technology, and Innovation in Health and Medicine
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIMH
|
2020
|
|
National Action Alliance for Suicide Prevention (NAASP)
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, HRSA, IHS, OS, OSG, SAMHSA
|
NIAAA, NIDA, NIMH, OD/ DPCPSI/ OBSSR, ODP
|
2010
|
|
National Action Plan for Combating Antoibiotic-Resistant Bacteria (CARB) 2020-2025
|
Committee, Advisory Group, or Work Group
|
AHRQ, BARDA, CDC, CMS, FDA, HRSA, OS
|
NIAID
|
2019
|
|
National Action Plan for the Elimination of multi-drug resistant Tuberculosis (MDR TB)
|
Other
|
CDC
|
CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA
|
2015
|
|
National Advisory Board for Medical Rehabilitation Research
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NHLBI, NIA, NIAMS, NICHD, NIDCD, NINDS, OD/ DPCPSI
|
1991
|
|
National Advisory Committee on Children and Disasters (NAACD)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, ASPR
|
NICHD, NIEHS
|
|
|
National Amyotrophic Lateral Sclerosis Registry
|
Resource Development
|
ATSDR, CDC
|
NINDS
|
2011
|
|
National Cancer Institute and HRSA Office of Women’s Health
Cervical Cancer Moonshot Roundtable Series:
Creating Capacity to Reduce Systems Barriers in Rural and Underserved Settings
|
Committee, Advisory Group, or Work Group
|
OASH, HRSA
|
NCI
|
2020
|
|
National Center for Advancing Translational Sciences (NCATS) Patient-focused Therapeutics Development Toolkit
|
Resource Development
|
FDA
|
NCATS
|
2017
|
|
National Clinical Care Commission (NCCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIDDK
|
2018
|
|
National Coalition for Oversite of Assisted Reproductive Technologies (NCOART)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
1997
|
|
National Collaborative on Childhood Obesity Research (NCCOR)
|
Research Initiative
|
CDC
|
NCI, NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR, ODP
|
2010
|
|
National Database for Antibiotic Resistant Organisms (NDARO)
|
Resource Development
|
CDC, FDA
|
CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIDA
|
2016
|
|
National Death Index Linkage Collaboration (NIH-NDI Agreement)
|
Resource Development
|
CDC
|
OD/ DPCPSI/ OBSSR, OD/ IMOD
|
2019
|
|
National Death Index Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NCATS, NCI, NHLBI, NIA, NIAID, NIDA, NICHD, NIMH, OD/ DPCPSI/ OBSSR
|
2018
|
|
National Emerging Contaminant Research Initiative
|
Research Initiative
|
CDC, ATSDR, FDA
|
NIEHS
|
|
|
National Family Health History Group
|
Public Education Campaign
|
CDC
|
CC, NHGRI, OD/ OSP
|
2005
|
|
National Health Interview Survey (NHIS) Cancer Control Supplement
|
Health Survey
|
CDC
|
NCI
|
1992
|
|
National Healthcare Quality and Disparities (NHQDR) Inter-Agency Workgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, HRSA
|
NCI, NIAID, NIEHS, NIMHD
|
2004
|
|
National Hispanic Science Network (NHSN)
|
Meeting/ Workshop
|
AHRQ, CDC, SAMHSA
|
NIAAA, NIDA, NIMH
|
2001
|
|
National Institute on Deafness and Other Communication Disorders (NIDCD) Directory of Organizations
|
Resource Development
|
AHRQ, CDC, CMS
|
NIDCD
|
1995
|
|
National Institutes of Health (NIH) Flow Cytometry Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NCI, NEI, NHLBI, NIAID, NIAMS, NIDCR
|
2005
|
|
National Institutes of Health (NIH) Metabolomics Scientific Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIA, NIAAA, NIAID, NIDCR, NIDDK, NIEHS, NIMH, NLM, OD/ DPCPSI/ ODS
|
2007
|
|
National Interagency Confederation for Biological Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
, NIAID, NCI
|
2002
|
|
National Neurological Conditions Surveillance System (NNCSS)
|
Research Initiative
|
CDC
|
NINDS
|
2016
|
|
National Pain Strategy. Provider Eduction Committee (NPS)
|
Meeting/ Workshop
|
CDC, HRSA, FDA, OASH
|
NINDS, OD/ DPCPSI/ ORWH
|
2016
|
|
National Response Team (NRT)
|
Resource Development
|
ASPR, ATSDR, CDC
|
NIEHS
|
2003
|
|
National Robotics Initiative (NRI)
|
Research Initiative
|
CDC
|
NCATS, NEI, NIA, NIBIB, NINR
|
2009
|
|
National Science Advisory Board for Biosecurity
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2004
|
|
National Science and Technology Council Subcommittee on Open Science (NSTC SOS)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, ASPR, CDC, FDA
|
NLM, OD/ OSP, OD/ OER
|
|
|
National Security Staff Dual Use Research of Concern Interagency Policy Committee (NSS DURC PCC)
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
NIAID, OD/ OSP
|
|
|
National Security Staff Dual Use Research of Concern Sub-Interagency Policy Committee (NSS DURC Sub-PCC)
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
NIAID, OD/ OSP
|
|
|
National Sexually Transmitted Infections (STI) Strategic Plan
|
Committee, Advisory Group, or Work Group
|
OASH, ACF, ACL, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIAID
|
2020
|
|
National Survey of Family Growth
|
Health Survey
|
ACF, CDC
|
NICHD
|
1973
|
|
National Toxicology Board of Scientific Counselors (NTP BSC)
|
Meeting/ Workshop
|
CDC, FDA
|
NIEHS
|
1978
|
|
National Toxicology Program Executive Committee (NTP EC)
|
Meeting/ Workshop
|
ATSDR, CDC, FDA, OASH
|
NIEHS
|
1978
|
|
National Toxicology Program Steering Committee (NTP SC)
|
Meeting/ Workshop
|
CDC, FDA
|
NIEHS
|
2003
|
|
Native American Research Center for Health (NARCH)
|
Research Initiative
|
IHS
|
CSR, NCI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH
|
2000
|
|
Natural Compounds to Reduce Nitrate in Meat Products: Phytome
|
Research Initiative
|
CDC
|
NCI
|
2016
|
|
Natural Experiments and Effectiveness Studies in the Prevention and Control of Diabetes
|
Research Initiative
|
CDC
|
NIDDK
|
2010
|
|
NCHS-CDC-NHANES, Audiometry, Balance, and Words in Noise Component
|
Health Survey
|
CDC
|
NIDCD
|
2018
|
|
NCI Cancer Data Standards Repository and Registry (caDSR)
|
Committee, Advisory Group, or Work Group
|
FDA
|
CIT, NCI, NEI, NHLBI, NIAMS, NIBIB, NICHD, NIMH, NINDS, NLM, NCATS
|
2003
|
|
NCI Clinical Trials and Translational Research Advisory Committee (CTAC)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCI
|
2007
|
|
NCI Convenes Workshop on Reproducibility of Fecal Microbiota Transplants in Cancer Therapeutics
|
Meeting/ Workshop
|
FDA
|
NCI, NIAID
|
2019
|
|
NCI Scientific Steering Committees (SSCs)
|
Research Initiative
|
FDA
|
NCI
|
2011
|
|
NCI's Surveillance, Epidemiology and End Results (SEER) cancer registry data and the Centers for Medicare & Medicaid Services' (CMS) Medicare Consumer Assessment of Healthcare Providers and Systems (CAHPS®) patient surveys.
|
Committee, Advisory Group, or Work Group
|
CMS
|
NCI
|
2013
|
|
NCI/CCR-FDA Clinical Investigator Program
|
Research Initiative
|
FDA
|
NCI
|
2015
|
|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
NCI
|
2007
|
|
NCI/FDA/HRSA/CMS Task Force on Cancer Diagnostic Devices (CD2) for Near-Patient Use
|
Committee, Advisory Group, or Work Group
|
CMS, FDA, HRSA
|
NCI
|
2019
|
|
Networking and Information Technology Research and Development (NITRD)
|
Research Initiative
|
AHRQ
|
NIGMS
|
1991
|
|
Neutron Radiobiology and Dosimetry Workshop Meeting Report
|
Meeting/ Workshop
|
ASPR
|
NIAID
|
2017
|
|
Newborn Screening Coding and Terminology Guide
|
Resource Development
|
CDC, FDA, HRSA, IOS
|
NHGRI, NHLBI, NICHD, NLM
|
2007
|
|
Newborn Screening Federal Partners Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD, NHGRI, NLM
|
2009
|
|
NGSP (formerly the National Glycohemoglobin Standardization Program)
|
Resource Development
|
CDC
|
NIDDK
|
1996
|
|
NHANES 2011-14 Accelerometer Data
|
Health Survey
|
CDC
|
NCI, NIA, NIDDK, NHLBI, OD/ DPCPSI/ OBSSR, ODP, OD/ DPCPSI/ ORWH
|
2009
|
|
NIA IMPACT Collaboratory Transforming Dementia Care
|
Research Initiative
|
CDC
|
NIA
|
2019
|
|
NIAID-CDC Joint US Partnership Implementing TB Elimination Research (JUPITER)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2007
|
|
NIAID/Armed Forces Radiobiology Research Institute (AFRRI) Research Coordination Team (RCT)
|
Committee, Advisory Group, or Work Group
|
ASPR
|
NIAID
|
2012
|
|
NIAID/CDC Dual Use Research of Concern (DURC) Risk Mitigation Reviews
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2015
|
|
NIAID/FDA/BARDA Meeting on Cutaneous Radiation Injuries
|
Meeting/ Workshop
|
BARDA, FDA
|
NIAID, NIGMS
|
2018
|
|
NIAID/FDA/BARDA Meeting on Radiation-Induced Lung Injuries
|
Meeting/ Workshop
|
FDA, ASPR
|
NIAID
|
2018
|
|
NIAID/NASA Medical Countermeasures Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA
|
NIAID, NCI, NHLBI
|
2017
|
|
Nicotine Research Cigarettes (SPECTRUM)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA
|
2013
|
|
NIEHS SBIR PHASE IIB Awards for Validation and Commericialization of Approaches to Reduce Animal Use in Toxicology Testing (U44)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIEHS
|
2016
|
|
NIH American Indian and Alaska Native Health Communications and Information Work Group
|
Committee, Advisory Group, or Work Group
|
ACL, IHS
|
NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDDK, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ THRO
|
2005
|
|
NIH Autoimmune Diseases Coordinating Committee (ADCC)
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
NIAID, OD, NCI, NCATS, NCCIH, NEI, NHLBI, NHGRI, NIAMS, NIBIB, NIEHS
|
2003
|
|
NIH Common Data Elements Task Force (CDETF)
|
Committee, Advisory Group, or Work Group
|
AHRQ, FDA, CMS
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NCRR, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODSS, OD/ OER
|
2012
|
|
NIH COVID-19 Treatment Guidelines Panel
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2020
|
|
NIH Guide for Grants and Contracts
|
Resource Development
|
AHRQ, CDC, FDA
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OER
|
2007
|
|
NIH Medical Rehabilitation Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA, SAMHSA
|
CC, CSR, NCCIH, NCI, NEI, NHLBI, NIA, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIMH, NINDS, NINR
|
1999
|
|
NIH Scientific Data Council for the Common Data Elements (CDE) Task Force
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
CC, CIT, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ SGMRO, OD/ OER, OD/ OSP
|
|
|
NIH, HUD, CDC Housing and Health Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NICHD, NIDDK, ODP
|
2019
|
|
NIH-BARDA Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA
|
NIAID
|
2018
|
|
NIH-CDC-IDSA Guidelines for Treatment of HIV Related Opportunistic Infections Among Adults and Adolescents
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, OD/ DPCPSI/ OAR
|
1989
|
|
NIH-FDA Interagency Clinical Outcome Assessments (ICOA) Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NCCIH, NCI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/ DPCPSI
|
2010
|
|
NIH-FDA Medical Device Research Interest Group (MDRIG)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCATS, NCI, NEI, NHLBI, NIA, NIAID, NIBIB, NICHD, NIDDK, NINR, OD/ DPCPSI/ ORIP, FIC, NIAMS, NIDA
|
2016
|
|
NIH/BARDA Antimicrobial Resistance (AMR) Diagnostic Challenge Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA, CDC
|
NIAID
|
2015
|
|
NIH/BMGF Collaboration - Point of Care Testing Working Group
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCI, NIAID, NIBIB, NICHD
|
2016
|
|
NINDS Common Data Elements Program
|
Resource Development
|
CDC, FDA
|
CIT, NINDS, NICHD, NEI, NHGRI, NCATS, NIA, NIMH, NIEHS, NIGMS, NIBIB, NIDDK, NIDCR, NINR, NHLBI
|
2006
|
|
Non-animal approaches to assess cardiotoxicity hazard
|
Research Initiative
|
FDA
|
NIEHS
|
2018
|
|
Northwest Portland Tribal Registry Project
|
Resource Development
|
IHS
|
NCI
|
1999
|
|
NSTC Subcommittee on Biological Defense Research and Development - Interagency Bioconvergence Working Group
|
Committee, Advisory Group, or Work Group
|
OS
|
OD/ OSP
|
2020
|
|
NSTC Subcommittee on Biological Sciences
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ OSP
|
|
|
NSTC Subcommittee on Biological Sciences -Interagency Synthetic Biology Working Group (BSSC-SBWG)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIBIB, OD/ OSP
|
2019
|
|
Nutrition Research Coordinating Committee (NRCC)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, ASPE, CDC, FDA, HRSA, OASH
|
OD/ DPCPSI/ ONR
|
1975
|
|
|